US Bancorp’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-437
| Closed | -$721 | – | 4257 |
|
|
2024
Q4 | $721 | Sell |
437
-151
| -26% | -$380 | ﹤0.01% | 3997 |
|
|
2024
Q3 | $2.06K | Sell |
588
-987
| -63% | -$3.84K | ﹤0.01% | 3778 |
|
|
2024
Q2 | $5.17K | Buy |
+1,575
| New | +$6.89K | ﹤0.01% | 3504 |
|
|
2024
Q1 | – | Sell |
-7,991
| Closed | -$29.9K | – | 4015 |
|
|
2023
Q4 | $29.9K | Buy |
7,991
+5,586
| +232% | +$13.2K | ﹤0.01% | 2894 |
|
|
2023
Q3 | $5.1K | Sell |
2,405
-1,922
| -44% | -$6.37K | ﹤0.01% | 3427 |
|
|
2023
Q2 | $20.6K | Buy |
4,327
+2,086
| +93% | +$11.5K | ﹤0.01% | 2961 |
|
|
2023
Q1 | $12.8K | Buy |
2,241
+935
| +72% | +$5.64K | ﹤0.01% | 3190 |
|
|
2022
Q4 | $13.2K | Sell |
1,306
-12,424
| -90% | -$233K | ﹤0.01% | 3205 |
|
|
2022
Q3 | $307K | Buy |
13,730
+13,362
| +3,631% | +$386K | ﹤0.01% | 1624 |
|
|
2022
Q2 | $9K | Buy |
368
+68
| +23% | +$1.88K | ﹤0.01% | 3388 |
|
|
2022
Q1 | $11K | Sell |
300
-180
| -38% | -$6.97K | ﹤0.01% | 3337 |
|
|
2021
Q4 | $28K | Sell |
480
-213
| -31% | -$12.1K | ﹤0.01% | 2932 |
|
|
2021
Q3 | $41K | Sell |
693
-97
| -12% | -$7.61K | ﹤0.01% | 2732 |
|
|
2021
Q2 | $68K | Buy |
790
+268
| +51% | +$21.6K | ﹤0.01% | 2503 |
|
|
2021
Q1 | $43K | Buy |
522
+407
| +354% | +$39K | ﹤0.01% | 2650 |
|
|
2020
Q4 | $11K | Buy |
115
+98
| +576% | +$6.09K | ﹤0.01% | 3142 |
|
|
2020
Q3 | $1K | Hold |
17
| – | – | ﹤0.01% | 3575 |
|
|
2020
Q2 | $1K | Buy |
+17
| New | +$507 | ﹤0.01% | 3592 |
|
|
2018
Q4 | – | Sell |
-922
| Closed | -$15K | – | 3615 |
|
|
2018
Q3 | $15K | Buy |
922
+62
| +7% | +$733 | ﹤0.01% | 3002 |
|
|
2018
Q2 | $10K | Buy |
+860
| New | +$9.47K | ﹤0.01% | 3126 |
|
Other funds holding FATE
RG
SSA
JJ
BBA
VPC